SYN2BIO SPÓŁKA AKCYJNA (S2B.WA) stock: key figures, P/E, revenue and dividend
Health Care · Poland · ISIN PLSNBIO00013
SYN2BIO SPÓŁKA AKCYJNA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 PLN | 0.00 PLN |
| Gross profit | 0.00 PLN | 0.00 PLN |
| Operating income | -19.89 m PLN | -28.93 m PLN |
| EBIT | -19.89 m PLN | -28.92 m PLN |
| Net income | -16.34 m PLN | -23.66 m PLN |
| Diluted EPS – continuing operations | -1.87 PLN | -2.71 PLN |
Full history since 2023, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SYN2BIO SPÓŁKA AKCYJNA
Syn2bio S.A. operates as a biotechnology company. It engages in the development and commercialization of SYN2 cardiotracer, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery disease. It also engages in the research of new pharmaceutical compounds and its further study, registration, and market launch as a medicinal product. Syn2bio S.A. was incorporated in 2025 and is based in Warsaw, Poland.
More stocks
- Asia Tech Image (4974.TWO)
- Pang Rim Spinn (003610.KS)
- Curiosis (494120.KQ)
- Sungei Bagan Rubber Malaya (2569.KL)
- Capital B SA (ALCPB.PA)
- Maiquer Group Co Ltd (002719.SZ)
- Taisol Electronics Co Ltd (3338.TW)
- Bonny Worldwide Ltd (8467.TW)
- N. Varveris-Moda Bagno S.A (MODA.AT)
- TDG Gold Corp (TDG.V)
- NEIGHBORHOOD INTELLIGENCE, INC. (NXH)
- Ion Electronic Materials Co., Ltd. (6959.TWO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.